LABO INTERNATIONAL S.r.l. (Halle B6 / Stand: F15)

Swiss Patented Transdermic Technology CH 711 466: A cutting-edge innovation incorporated into Labo’s iconic products: Crescina, Fillerina, and Collagenina.
The Swiss Patented Transdermic Technology CH 711 466 is at the heart of Labo’s products.

It consists of special patented formulations combining:

  • active ingredients with differentiated and very low molecular weights for in-depth penetration;
  • enhancers to boost the penetration capability.

This advanced technology ensures the active ingredients to penetrate several layers of the skin and the scalp, delivering extraordinary results.
Indeed, the larger molecules that remain in the skin surface work on the superficial layer of the skin/scalp. At the same time, the smaller molecules can reach the deeper layers delivering their effects where they’re most needed.
Labo’s Patented Transdermic Technology goes beyond surface-level improvements, offering visible, long-lasting results by ensuring that active ingredients perform their best and without the need for invasive procedures. This makes Labo products a top choice for those seeking effective, science-backed solutions for their skin and hair concerns.

Target Group: Consumers who want to achieve visible results and improvements in their skin and hair without undergoing invasive treatments such as microinjections or hair transplant.

 

 

_________________________________________________________________________________

 

Conval Group Validasyon Egitimi ve Danismanlik Tic. Ltd Sti. (Halle B6 /Stand: E12)

At Expopharm, RC-Group will be presenting its advanced validation and qualification services for the pharmaceutical, biotechnological, and medical device industries. Our focus is on delivering cutting-edge solutions that ensure compliance, efficiency, and safety in production processes, particularly through our specialized consulting services in Good Manufacturing Practices (GMP) and Good Distribution Practices (GDP).
We are dedicated to providing innovative software solutions that help life sciences companies meet the highest regulatory standards with ease. Our suite of software products is designed to simplify compliance, streamline validation processes, and ensure seamless operations in highly regulated environments.
One of our flagship products, e-VLM (Electronic Validation Lifecycle Management), offers a complete, digital solution for managing the entire validation lifecycle.
From planning and execution to reporting and monitoring, e-VLM empowers teams to work efficiently while maintaining full control over compliance requirements.

RC-Group provides tailored validation and qualification services that are crucial for maintaining high standards in pharmaceutical production. Our innovations lie in our ability to offer highly customized solutions, ensuring that each client’s specific needs are met with precision, compliance, and operational excellence.
We deliver innovative software solutions that simplify compliance and streamline validation for life sciences companies.
Our flagship product, e-VLM, provides a complete digital solution for managing the entire validation lifecycle. With automation, real-time monitoring, scalability, and compliance with global standards (FDA, EMA, GxP), Rescop Software ensures efficient, audit-ready results, helping you focus on innovation while staying fully compliant.

Target Group: Our services are particularly relevant for pharmaceutical manufacturers, biotechnological companies, and medical device producers who prioritize compliance with international standards and seek expert guidance in validation and qualification processes.